SAN

81.92

+1.19%↑

SAN

81.92

+1.19%↑

SAN

81.92

+1.19%↑

SAN

81.92

+1.19%↑

SAN

81.92

+1.19%↑

Search

Vetoquinol SA

Fechado

SetorSaúde

84.3 -2.2

Visão Geral

Variação de preço das ações

24h

Atual

Mín

83.8

Máximo

87.5

Indicadores-chave

By Trading Economics

Rendimento

25M

Vendas

258M

P/E

Médio do Setor

16.569

84.243

Rendimento de Dividendos

1.02

Margem de lucro

9.734

Funcionários

2,497

EBITDA

48M

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

1.02%

2.28%

Próximos Ganhos

27 de mar. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

1B

Abertura anterior

86.5

Fecho anterior

84.3

Sentimento de Notícias

By Acuity

50%

50%

151 / 352 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Bearish Evidence

Vetoquinol SA Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

5 de fev. de 2026, 00:00 UTC

Ações em Alta

Stocks to Watch: Crown Castle, Qualcomm, Arm, U-Haul

4 de fev. de 2026, 22:55 UTC

Ganhos

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook -- Update

4 de fev. de 2026, 21:44 UTC

Ganhos

Arm Holdings 3Q Profit Falls Despite Revenue Growth

4 de fev. de 2026, 21:39 UTC

Ganhos

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook

5 de fev. de 2026, 00:00 UTC

Ganhos

Renesas Electronics FY Loss Y51.76B Vs Net Y219.08B

5 de fev. de 2026, 00:00 UTC

Ganhos

Renesas Electronics FY Loss Y51.76B Vs Net Y219.08B

4 de fev. de 2026, 23:46 UTC

Conversa de Mercado

Nikkei May Rise as Weaker Yen Supports Earnings Hopes -- Market Talk

4 de fev. de 2026, 23:45 UTC

Ganhos

Google to Double Spending as Earnings Beat Wall Street Expectations -- 4th Update

4 de fev. de 2026, 23:32 UTC

Conversa de Mercado

Gold Rises on Possible Dip-Buying Amid Lingering U.S.-Iran Tensions -- Market Talk

4 de fev. de 2026, 22:59 UTC

Aquisições, Fusões, Aquisições de Empresas

SiTime to Buy Timing Business From Renesas Electronics For $1.5B

4 de fev. de 2026, 22:30 UTC

Ganhos

Salesforce Stock Is Battered, and Super Cheap. Hang Tight. -- Barrons.com

4 de fev. de 2026, 22:30 UTC

Ganhos

Alphabet's Cloud Is Shining as CapEx Heads Even Higher -- Barrons.com

4 de fev. de 2026, 22:21 UTC

Ganhos

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

4 de fev. de 2026, 22:17 UTC

Conversa de Mercado

WiseTech Faces Risks in Both Directions From DSV's Progress -- Market Talk

4 de fev. de 2026, 22:15 UTC

Conversa de Mercado

Santos Should Lay Out Strategic Plans at Annual Result -- Market Talk

4 de fev. de 2026, 22:00 UTC

Conversa de Mercado

ESG Roundup: Market Talk

4 de fev. de 2026, 21:53 UTC

Ganhos

Google to Double Spending as Earnings Beat Wall Street Expectations -- 3rd Update

4 de fev. de 2026, 21:51 UTC

Ganhos

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

4 de fev. de 2026, 21:50 UTC

Conversa de Mercado

Tech, Media & Telecom Roundup: Market Talk

4 de fev. de 2026, 21:50 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Financial Services Roundup: Market Talk

4 de fev. de 2026, 21:50 UTC

Conversa de Mercado
Ganhos

Auto & Transport Roundup: Market Talk

4 de fev. de 2026, 21:50 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

4 de fev. de 2026, 21:45 UTC

Ganhos

Arm Holdings Reported Record Revenue. The Stock is Falling. -- Barrons.com

4 de fev. de 2026, 21:44 UTC

Ganhos

Qualcomm Gives Weak Guidance. The CEO Blames Memory Crunch. -- Barrons.com

4 de fev. de 2026, 21:43 UTC

Ganhos

Google to Double Spending as Earnings Beat Wall Street Expectations -- 2nd Update

4 de fev. de 2026, 21:41 UTC

Ganhos

These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More -- Barrons.com

4 de fev. de 2026, 21:36 UTC

Conversa de Mercado

Latest Canada Green Bond Raises C$2 Billion -- Market Talk

4 de fev. de 2026, 21:30 UTC

Ganhos

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

4 de fev. de 2026, 21:30 UTC

Ganhos

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

4 de fev. de 2026, 21:30 UTC

Ganhos

Beach Energy Interim Dividend 1 Australian Cent/Sjare

Comparação entre Pares

Variação de preço

Vetoquinol SA Previsão

Consenso de Avaliação

By TipRanks

0 ratings

0

Comprar

0

Manter

0

Vender

Pontuação Técnica

By Trading Central

72.6 / 75.1Suporte e Resistência

Curto Prazo

Bearish Evidence

Médio Prazo

Bearish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

151 / 352 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Vetoquinol SA

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.
help-icon Live chat